Cited by 3,163Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulation

The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.

Blinded by the Light: The Growing Complexity of p53

Open access

Vousden, Karen H., Prives, Carol·2009·Cell

DOI 10.1016/j.cell.2009.04.037

Open this paper in CoChat — free account Open PDF

Abstract

While the tumor suppressor functions of p53 have long been recognized, the contribution of p53 to numerous other aspects of disease and normal life is only now being appreciated. This burgeoning range of responses to p53 is reflected by an increasing variety of mechanisms through which p53 can function, although the ability to activate transcription remains key to p53's modus operandi. Control of p53's transcriptional activity is crucial for determining which p53 response is activated, a decision we must understand if we are to exploit efficiently the next generation of drugs that selectively activate or inhibit p53.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2009.04.037

Cites

231 of 231 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
Retracted
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Self-citation
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921

Show all 232 references

Sorted by citations

Items 801–900 of 1,016

Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence
Tavana, O., Benjamin, C. L., Puebla‐Osorio, N., Sang, M., Ullrich, S. E., Ananthaswamy, H. N., & Zhu, C. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12688 · Cited by 62
MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
Stindt, M., Carter, S. A., Vigneron, A. M., Ryan, K. M., & Vousden, K. H. (2011) · Cell Cycle · doi:10.4161/cc.10.18.17436 · Cited by 62
Self-citation
A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression
Kinnaird, J. H., Weir, W., Durrani, Z., Pillai, S. S., Baird, M., & Shiels, B. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066833 · Cited by 62
Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner
Yang, H. J., Zhang, J., Yan, W., Cho, S.-J., Lucchesi, C. A., Chen, M., Huang, E. C., Scoumanne, A., Zhang, W., & Chen, X. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711814114 · Cited by 62
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
He, Y., & Kaina, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071562 · Cited by 62
The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children
He, J., Wang, F., Zhu, J., Zhang, Z., Zou, Y., Zhang, R., Yang, T., & Xia, H. (2017) · Aging · doi:10.18632/aging.101196 · Cited by 61
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Wang, M., & Attardi, L. D. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-025840 · Cited by 61
TFF1 activates p53 through down-regulation of miR-504 in gastric cancer
Soutto, M., Chen, Z., Saleh, M. A., Katsha, A. M., Zhu, S., Zaika, A. I., Belkhiri, A., & El-Rifai, W. M. (2014) · Oncotarget · doi:10.18632/oncotarget.2156 · Cited by 61
Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro
Zhang, F., Kong, D., Zhang, Z., Lei, N., Zhu, X.-J., Zhang, X.-P., Chen, L., Lu, Y., & Zheng, S. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0791-5 · Cited by 61
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
Quigley, D. A., Silwal‐Pandit, L., Dannenfelser, R., Langerød, A., Vollan, H. K. M., Vaske, C. J., Siegel, J. U., Troyanskaya, O. G., Chin, S., Caldas, C., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0387 · Cited by 61
Educational paper
Teplick, A., Kowalski, M., Biegel, J. A., & Nichols, K. E. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-010-1377-2 · Cited by 61
Phosphorylation of p53 by TAF1 Inactivates p53-Dependent Transcription in the DNA Damage Response
Wu, Y., Lin, J., Piluso, L. G., Dhahbi, J. M., Bobadilla, S., Spindler, S. R., & Liu, X. E. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.031 · Cited by 61
Phenotype Specific Analyses Reveal Distinct Regulatory Mechanism for Chronically Activated p53
Kirschner, K., Samarajiwa, S., Cairns, J., Menon, S., Pérez-Mancera, P. A., Tomimatsu, K., Bermejo‐Rodríguez, C., Ito, Y., Chandra, T., Narita, M., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005053 · Cited by 61
The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injury
Dagher, P. C., Mai, E., Hato, T., Lee, S., Anderson, M. D., Karozos, S. C., Mang, H. E., Knipe, N. L., Plotkin, Z., & Sutton, T. A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00317.2011 · Cited by 61
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care
Rosa, M. D., Rega, D., Costabile, V., Duraturo, F., Niglio, A., Izzo, P., Pace, U., & Delrio, P. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16659790 · Cited by 61
Parkinson's disease‐associated protein Parkin: an unusual player in cancer
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0314-z · Cited by 61
Selective killing of p53‐deficient cancer cells by SP600125
Jèmaà, M., Vitale, I., Kepp, O., Berardinelli, F., Galluzzi, L., Senovilla, L., Mariño, G., Malik, S. A., Rello‐Varona, S., Lissa, D., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200228 · Cited by 60
Making sense of ubiquitin ligases that regulate p53
Jain, A. K., & Barton, M. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13445 · Cited by 60
To repress or not to repress: This is the guardian's question
Rinn, J. L., & Huarte, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.002 · Cited by 60
Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
He, K., Zheng, X., Zhang, L., & Yu, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0284 · Cited by 60
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex
Fischer, M., Quaas, M., Nickel, A., & Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6356 · Cited by 60
Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity
Sung, Y.-J., Kao, T., Kuo, C., Fan, C., Cheng, A. N., Fang, W., Chou, H.-Y., Lo, Y.-K., Chen, C., Jiang, S. S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0730-7 · Cited by 60
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease
Blandino, G., Valenti, F., Sacconi, A., & Agostino, S. D. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.011 · Cited by 60
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Dutta, S., Pregartner, G., Rücker, F. G., Heitzer, E., Zebisch, A., Bullinger, L., Berghold, A., Döhner, K., & Sill, H. (2020) · Cancers · doi:10.3390/cancers12030637 · Cited by 60
CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress
Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Ogretmen, B., Krupenko, S. A., & Krupenko, N. I. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716902 · Cited by 59
PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53
Wang, W., Wei, J., Zhang, H., Zheng, X., Zhou, H., Luo, Y., Yang, J., Deng, Q., Huang, S., & Fu, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03888-1 · Cited by 59
TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer
Pan, M., Jiang, C., Tse, P., Achacoso, N., Alexeeff, S., Solorzano, A. V., Chung, E., Hu, W., Truong, T.-G., Arora, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.02014 · Cited by 59
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Sheikh, K., Amjad, M., Irfan, M., Anjum, S., Majeed, T., Riaz, M. U., Jassim, A. Y., Sharif, E., & Ibrahim, W. N. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s493643 · Cited by 61
ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53
Zhang, J., Cao, M., Dong, J., Li, C., Xu, W., Zhan, Y., Wang, X., Yu, M., Ge, C., Ge, Z., et al. (2014) · Nature Communications · doi:10.1038/ncomms6059 · Cited by 59
Roles of tumor suppressors in regulating tumor-associated inflammation
Yang, L., & Karin, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.131 · Cited by 59
Rap2b, a novel p53 target, regulates p53-mediated pro-survival function
Zhang, X., He, Y., Lee, K. H., Dubois, W., Li, Z., Wu, X., Kovalchuk, A. L., Zhang, W., & Huang, J. L. (2013) · Cell Cycle · doi:10.4161/cc.24364 · Cited by 59
Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial
Fernandez‐Cuesta, L., Oakman, C. A., Falagan-Lotsch, P., Smoth, K.-S., Quinaux, E., Buyse, M. E., Dolci, M. S., de Azambuja, E., Hainaut, P. L., Dell’Orto, P., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3179 · Cited by 59
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival
Mullany, L. K., Wong, K., Marciano, D. C., Katsonis, P., King, E. R., Ren, Y. A., Lichtarge, O., & Richards, J. S. (2015) · Neoplasia · doi:10.1016/j.neo.2015.10.003 · Cited by 59
Gain of function of mutant p53: R282W on the peak?
Zhang, Y., Coillie, S. V., Fang, J.-Y., & Xu, J. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.8 · Cited by 59
The RNA Response to DNA Damage
Giono, L. E., Moreno, N. N., Botto, A. E. C., Dujardin, G., Muñoz, M. J., & Kornblihtt, A. R. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.004 · Cited by 59
p53 tumor suppressor and iron homeostasis
Zhang, J., & Chen, X. (2018) · FEBS Journal · doi:10.1111/febs.14638 · Cited by 59
Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis
Fedorova, O., Petukhov, A., Daks, A. A., Shuvalov, O. Y., Leonova, T., Vasileva, E., Aksenov, N. D., Melino, G., & Barlev, N. A. (2018) · Oncogene · doi:10.1038/s41388-018-0566-8 · Cited by 59
The vanillin derivative VND3207 protects intestine against radiation injury by modulating p53/NOXA signaling pathway and restoring the balance of gut microbiota
Li, M., Gu, M.-M., Lang, Y., Shi, J., Chen, B. P. C., Guan, H., Yu, L., Zhou, P., & Shang, Z. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.035 · Cited by 59
Lovastatin‐mediated MCF‐7 cancer cell death involves LKB1‐AMPK‐p38MAPK‐p53‐survivin signalling cascade
Huang, S., Chyuan, I., Shiue, C., Yu, M., Hsu, Y., & Hsu, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14879 · Cited by 59
MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia models
Fang, D. D., Tang, Q., Kong, Y., Rong, T., Wang, Q., Li, N., Fang, X., Gu, J., Xiong, D., Yin, Y., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00465-5 · Cited by 58
TP53 dysfunction in diffuse large B-cell lymphoma
Lu, T., Young, K. H., Xu, W., & Li, J.-Y. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.006 · Cited by 58
p53 isoforms gain functions
Olivares‐Illana, V., & Fåhræus, R. (2010) · Oncogene · doi:10.1038/onc.2010.266 · Cited by 58
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58
To be, or not to be
Wang, S.-J., & Gu, W. J. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000024 · Cited by 58
The dual role of p53: DNA protection and antioxidant
Borrás, C., Gómez‐Cabrera, M. C., & Viña, J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.571685 · Cited by 58
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 58
Mdm2 and MdmX as Regulators of Gene Expression
Biderman, L., Manley, J. L., & Prives, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912455331 · Cited by 58
Self-citation
PIASy-mediated Tip60 sumoylation regulates p53-induced autophagy
Naidu, S. R., Lakhter, A. J., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.21091 · Cited by 58
Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
Koster, R., van Vugt, M. A. T. M., Timmer‐Bosscha, H., Gietema, J. A., & de Jong, S. (2013) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2013.13 · Cited by 58
Proline dehydrogenase promotes senescence through the generation of reactive oxygen species
Nagano, T., Nakashima, A., Onishi, K., Kawai, K., Awai, Y., Kinugasa, M., Iwasaki, T., Kikkawa, U., & Kamada, S. (2017) · Journal of Cell Science · doi:10.1242/jcs.196469 · Cited by 58
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
Tazawa, H., Kuroda, S., Hasei, J., Kagawa, S., & Fujiwara, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071479 · Cited by 58
Cell cycle regulation and apoptosis mediated by p53 in response to hypoxia in hepatopancreas of the white shrimp Litopenaeus vannamei
Nuñez-Hernandez, D. M., Félix-Portillo, M., Peregrino-Uriarte, A. B., & Yepiz-Plascencia, G. M. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.09.131 · Cited by 58
Suppression of cell cycle progression by Jun dimerization protein (JDP2) involves down-regulation of cyclin A2Preprint
Pan, J., Nakade, K., Huang, Y.-C., Zhu, Z.-W., Masuzaki, S., Hasegawa, H., Murata, T., Yoshiki, A., Yamaguchi, N., Lee, C., et al. (2009) · Nature Precedings · doi:10.1038/onc.2010.355 · Cited by 58
Molecular and Cellular Mechanisms of Apoptosis during Dissociated Spermatogenesis
Liu, T., Wang, L., Chen, H., Huang, Y., Yang, P., Ahmed, N., Wang, T., Liu, Y., & Chen, Q. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00188 · Cited by 57
Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11
Wang, C., Liu, H., Xu, S., Deng, Y. L., Xu, B., Yang, T., & Liu, W. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01343-7 · Cited by 57
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate
Scala, F., Brighenti, E., Govoni, M., Imbrogno, E., Fornari, F., Treré, D., Montanaro, L., & Derenzini, M. (2015) · Oncogene · doi:10.1038/onc.2015.147 · Cited by 59
Autophagy and senescence, stress responses induced by the DNA-damaging mycotoxin alternariol
Solhaug, A., Torgersen, M. L., Holme, J. A., Lagadic‐Gossmann, D., & Eriksen, G. S. (2014) · Toxicology · doi:10.1016/j.tox.2014.10.009 · Cited by 57
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
Akeno, N., Miller, A. L., Ma, X., & Wikenheiser‐Brokamp, K. A. (2014) · Oncogene · doi:10.1038/onc.2013.589 · Cited by 57
Cysteine-Conjugated Metabolites of Ginger Components, Shogaols, Induce Apoptosis through Oxidative Stress-Mediated p53 Pathway in Human Colon Cancer Cells
Fu, J., Chen, H., Soroka, D. N., Warin, R., & Sang, S. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501351r · Cited by 57
p53 Basic C Terminus Regulates p53 Functions through DNA Binding Modulation of Subset of Target Genes
Hamard, P.-J., Lukin, D. J., & Manfredi, J. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331298 · Cited by 57
Crystal Structure of a Multidomain Human p53 Tetramer Bound to the Natural CDKN1A (p21) p53-Response Element
Emamzadah, S., Tropia, L., & Halazonetis, T. D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0351 · Cited by 57
Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies
Feng, Y., Zhou, L., Sun, X., & Li, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.14723 · Cited by 57
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure
Liu, S., Kim, T.-H., Franklin, D. A., & Zhang, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.086 · Cited by 57
Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2
Choi, B.-K., Dayaram, T., Parikh, N., Wilkins, A. D., Nagarajan, M., Novikov, I. B., Bachman, B. J., Jung, S. Y., Haas, P. J., Labrie, J. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806643115 · Cited by 57
Tumor suppressor p53 cross-talks with TRIM family proteins
Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 57
Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
Qiao, Y., Agboola, O. S., Hu, X., Wu, Y., & Lei, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10042-5 · Cited by 57
p53, Aerobic Metabolism, and Cancer
Lago, C. U., Sung, H. J., Ma, W., Wang, P., & Hwang, P. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3650 · Cited by 57
Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation
Yakovlev, V. A., Bayden, A. S., Graves, P. R., Kellogg, G. E., & Mikkelsen, R. B. (2010) · Biochemistry · doi:10.1021/bi100564w · Cited by 56
Aberrant Autolysosomal Regulation Is Linked to The Induction of Embryonic Senescence: Differential Roles of Beclin 1 and p53 in Vertebrate Spns1 Deficiency
Sasaki, T., Lian, S., Qi, J., Bayliss, P. E., Carr, C. E., Johnson, J. L., Guha, S., Kobler, P., Catz, S. D., Gill, M. S., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004409 · Cited by 57
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 56
Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes
Olivier, M., & Tanière, P. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283412dfa · Cited by 56
p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition
Brosh, R., Assia-Alroy, Y., Molchadsky, A., Bornstein, C., Dekel, E., Madar, S., Shetzer, Y., Rivlin, N., Goldfinger, N., Sarig, R., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.125 · Cited by 56
p53 spreads out further: suppression of EMT and stemness by activating miR-200c expression
Schubert, J., & Brabletz, T. (2011) · Cell Research · doi:10.1038/cr.2011.62 · Cited by 56
Identification of new p53 target microRNAs by bioinformatics and functional analysis
Bisio, A., Sanctis, V. D., Vescovo, V. D., Denti, M. A., Jegga, A. G., Inga, A., & Ciribilli, Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-552 · Cited by 56
Sumoylation in gene regulation, human disease, and therapeutic action
Yang, X., & Chiang, C. (2013) · F1000Prime Reports · doi:10.12703/p5-45 · Cited by 56
Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53
Hafsi, H., Santos‐Silva, D., Courtois-Cox, S., & Hainaut, P. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-134 · Cited by 56
Molecular mechanisms of hepatic apoptosis regulated by nuclear factors
Wang, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.038 · Cited by 56
FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis
Huang, C., Du, J., & Xie, K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.002 · Cited by 56
MicroRNA Cancer Regulation
Schmitz, U., Wolkenhauer, O., & Vera, J. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1 · Cited by 56
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
Arif, T., Paul, A., Krelin, Y., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2018) · Cancers · doi:10.3390/cancers10120499 · Cited by 57
BDE-209 induces male reproductive toxicity via cell cycle arrest and apoptosis mediated by DNA damage response signaling pathways
Li, X., Zhu, Y., Zhang, C., Liu, J., Zhou, G., Li, J., Shi, Z., Sun, Z., & Zhou, X. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113097 · Cited by 56
p53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence
Sagiv, A., Bar-Shai, A., Levi, N., Hatzav, M., Zada, L., Ovadya, Y., Roitman, L., Manella, G., Regev, O., Majewska, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.009 · Cited by 55
MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling
Zhang, C., Liu, J., Wang, X., Wu, R., Lin, M., Laddha, S. V., Yang, Q., Chan, C. S., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2379 · Cited by 55
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability
Fu, X., & Xu, Y. (2012) · Genome Medicine · doi:10.1186/gm354 · Cited by 55
miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop
Zhang, Y., Dai, J., Deng, H., Wan, H., Liu, M., Wang, J., Li, S., Li, X., & Tang, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.593 · Cited by 55
Role of MnSOD and p66shc in Mitochondrial Response to p53
Pani, G., & Galeotti, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3499 · Cited by 55
RAG-induced DNA double-strand breaks signal through Pim2 to promote pre–B cell survival and limit proliferation
Bednarski, J. J., Nickless, A., Bhattacharya, D., Amin, R. H., Schlissel, M. S., & Sleckman, B. P. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20112078 · Cited by 55
MicroRNAs, wild-type and mutant p53: More questions than answers
Jones, M. F., & Lal, A. (2012) · RNA Biology · doi:10.4161/rna.20146 · Cited by 55
Melatonin Enhances Palladium-Nanoparticle-Induced Cytotoxicity and Apoptosis in Human Lung Epithelial Adenocarcinoma Cells A549 and H1229
Gurunathan, S., Jeyaraj, M., Kang, M.-H., & Kim, J. (2020) · Antioxidants · doi:10.3390/antiox9040357 · Cited by 55
miR-205 in Breast Cancer: State of the Art
Plantamura, I., Cataldo, A., Cosentino, G., & Iorio, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010027 · Cited by 55
Differential Toxicity of DNA Adducts of Mitomycin C
Bargonetti, J., Champeil, É., & Tomasz, M. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/698960 · Cited by 55
USP7 enforces heterochromatinization of p53 target promoters by protecting SUV39H1 from MDM2-mediated degradation.
Mungamuri, S. K., Qiao, R. F., Yao, S., Manfredi, J. J., Gu, W., & Aaronson, S. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.049 · Cited by 54
The role of p53 in the alternation of vascular functions
Chan, G. H. H., Chan, E., Kwok, C. T., Leung, G., Lee, S. M., & Seto, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981152 · Cited by 54
Inactivation of arf-bp1 Induces p53 Activation and Diabetic Phenotypes in Mice
Kon, N., Zhong, J., Qiang, L., Accili, D., & Gu, W. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322867 · Cited by 54
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Li, M., & Gu, W. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.020 · Cited by 54
Metabolic effect of TAp63α: enhanced glycolysis and pentose phosphate pathway, resulting in increased antioxidant defense
D’Alessandro, A., Amelio, I., Berkers, C. R., Antonov, A., Vousden, K. H., Melino, G., & Zolla, L. (2014) · Oncotarget · doi:10.18632/oncotarget.2300 · Cited by 54
Self-citation
Nuclear proteins acting on mitochondria
Lindenboim, L., Borner, C., & Stein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.016 · Cited by 54
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 54
SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS
Huang, Y., Hale, J., Wang, Y., Li, W., Zhang, S., Zhang, J., Zhao, H., Guo, X., Liu, J., Yan, H., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0558-8 · Cited by 54
p53-mediated heterochromatin reorganization regulates its cell fate decisions.
Mungamuri, S. K., Benson, E. K., Wang, S., Gu, W., Lee, S. W., & Aaronson, S. A. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2271 · Cited by 53

Authors: Vousden, K. H., & Prives, C.
Affiliations: Cancer Research UK Scotland Institute (GB)
Columbia University (US)
Corresponding author: Vousden, Karen H.
Prives, Carol
ORCID: Vousden, Karen H.
Prives, Carol
Venue: Cell
Publisher: Elsevier BV
Published: 2009-05
Volume: 137
Issue: 3
Pages: 413-431
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2009.04.037
OpenAlex: W2133959309
Semantic Scholar: 018e8ed8c8694d45cfd9ffaf967368345fe22af6
Cited by: 3,163
References: 232
Citations by year: 2026: 128 · 2025: 154 · 2024: 127 · 2023: 168 · 2022: 149 · 2021: 166 · 2020: 175 · 2019: 149 · 2018: 171 · 2017: 191 · 2016: 228 · 2015: 202 · 2014: 258 · 2013: 263 · 2012: 228
FWCI: 17.35
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1538 d)
doi.org/10.15223/policy-017 (stm-asf)
doi.org/10.15223/policy-037 (stm-asf)
doi.org/10.15223/policy-012 (stm-asf)
doi.org/10.15223/policy-029 (stm-asf)
doi.org/10.15223/policy-004 (stm-asf)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
National Cancer Institute (R01CA077742, CA77742)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, transcriptional activation, p53 activators, p53 inhibitors, p53 regulation
MeSH terms: Animals, Cell Survival, Cell Transformation, Neoplastic, Gene Expression Regulation, Humans, Mutation, Stress, Physiological, Transcriptional Activation, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Blinded by the Light: The Growing Complexity of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks